Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Equity (2021 - 2023)

Historic Return on Equity for Cullinan Therapeutics (CGEM) over the last 3 years, with Q3 2023 value amounting to 0.32%.

  • Cullinan Therapeutics' Return on Equity fell 4900.0% to 0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.32%, marking a year-over-year decrease of 4900.0%. This contributed to the annual value of 0.23% for FY2022, which is 4400.0% up from last year.
  • According to the latest figures from Q3 2023, Cullinan Therapeutics' Return on Equity is 0.32%, which was down 4900.0% from 0.29% recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Return on Equity high stood at 0.21% for Q2 2022, and its period low was 0.32% during Q3 2023.
  • Over the past 3 years, Cullinan Therapeutics' median Return on Equity value was 0.03% (recorded in 2021), while the average stood at 0.03%.
  • As far as peak fluctuations go, Cullinan Therapeutics' Return on Equity skyrocketed by 3500bps in 2022, and later tumbled by -5000bps in 2023.
  • Cullinan Therapeutics' Return on Equity (Quarter) stood at 0.15% in 2021, then skyrocketed by 226bps to 0.19% in 2022, then crashed by -266bps to 0.32% in 2023.
  • Its last three reported values are 0.32% in Q3 2023, 0.29% for Q2 2023, and 0.13% during Q1 2023.